FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

385060002: Prolonged-release oral tablet (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3636013018 Prolonged-release oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module
3636014012 Prolonged-release oral tablet (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3636019019 Extended-release oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module

5 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release oral tablet Is a Tablet false Inferred relationship Existential restriction modifier
Prolonged-release oral tablet Is a Conventional release oral tablet false Inferred relationship Existential restriction modifier
Prolonged-release oral tablet Has dose form intended site Oral true Inferred relationship Existential restriction modifier
Prolonged-release oral tablet Is a Modified-release oral tablet true Inferred relationship Existential restriction modifier
Prolonged-release oral tablet Has dose form administration method Swallow true Inferred relationship Existential restriction modifier
Prolonged-release oral tablet Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Prolonged-release oral tablet Has dose form release characteristic Prolonged-release true Inferred relationship Existential restriction modifier
Prolonged-release oral tablet Has basic dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely metformin hydrochloride 1 gram/1 each prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Pioglitazone 15mg + metformin 1g prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Trandolapril+verapamil hydrochloride 1mg/240mg prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely theophylline 300 milligram/1 each prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Metoprolol succinate 25mg prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely guaifenesin 600 milligram/1 each prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Verapamil hydrochloride 400mg prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely darifenacin (as darifenacin hydrobromide) 15 milligram/1 each prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Disopyramide phosphate 100mg prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Theophylline, anhydrous 600mg prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Orphenadrine citrate 100mg prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely oxycodone hydrochloride 40 milligram/1 each prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely hydrochlorothiazide 25 milligram and metoprolol tartrate 200 milligram/1 each prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Nifedipine 90mg prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely isosorbide mononitrate 60 milligram/1 each prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Quinidine sulfate 300mg prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Oxycodone hydrochloride 160mg prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely isosorbide dinitrate 40 milligram/1 each prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Ferrous glycine sulfate 562.5mg prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Metoprolol succinate 50mg prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely felodipine 2.5 milligram/1 each prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely mirabegron 25 milligram/1 each prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Loratadine+pseudoephedrine sulfate 5mg/120mg prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely tramadol hydrochloride 400 milligram/1 each prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely mirabegron 50 milligram/1 each prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Metronidazole 750mg prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Methamphetamine hydrochloride 10mg prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely isosorbide mononitrate 40 milligram/1 each prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely valproate sodium 500 milligram/1 each prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Guaifenesin 600mg /pseudoephedrine 60mg prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Procainamide hydrochloride 250mg prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely nicotinic acid 750 milligram/1 each prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Chlorpheniramine maleate + methscopolamine nitrate + pseudoephedrine hydrochloride 8mg/2.5mg/120mg prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Bupropion hydrochloride 100mg prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely fesoterodine fumarate 8 milligram/1 each prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely morphine sulfate 100 milligram/1 each prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Bupropion hydrochloride 300mg prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Bupropion hydrochloride 200mg prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely nicotinic acid 500 milligram/1 each prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Guaifenesin 1200mg prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely felodipine 10 milligram/1 each prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely fluvastatin (as fluvastatin sodium) 80 milligram/1 each prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Diltiazem 180mg prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely lithium carbonate 200 milligram/1 each prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Tacrolimus 750microgram prolonged-release orale tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely carbamazepine 200 milligram/1 each prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Divalproex sodium 500mg prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely nifedipine 30 milligram/1 each prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Desloratadine 2.5mg/pseudoephedrine 120mg prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Fexofenadine hydrochloride+pseudoephedrine hydrochloride 60mg/120 mg prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely metoclopramide hydrochloride 15 milligram/1 each prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Diltiazem 300mg prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely felodipine 5 milligram/1 each prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely gliclazide 30 milligram/1 each prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely nifedipine 40 milligram/1 each prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely darifenacin (as darifenacin hydrobromide) 7.5 milligram/1 each prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Ferrous sulfate 325mg prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Fexofenadine hydrochloride+pseudoephedrine hydrochloride 180mg/240mg prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely nisoldipine 30 milligram/1 each prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely fesoterodine fumarate 4 milligram/1 each prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely diclofenac sodium 75 milligram/1 each prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Isradipine 5mg prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Nicotinic acid 375mg prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely verapamil hydrochloride 120 milligram/1 each prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely oxybutynin hydrochloride 5 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely oxybutynin hydrochloride 10 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely nicotinic acid 1 gram and simvastatin 20 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely nicotinic acid 750 milligram and simvastatin 20 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely nicotinic acid 500 milligram and simvastatin 20 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely guanfacine (as guanfacine hydrochloride) 1 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely guanfacine (as guanfacine hydrochloride) 2 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely guanfacine (as guanfacine hydrochloride) 3 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely guaifenesin 1.2 gram and pseudoephedrine hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely guanfacine (as guanfacine hydrochloride) 4 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely guaifenesin 600 milligram and pseudoephedrine hydrochloride 60 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely dextromethorphan hydrobromide 60 milligram and guaifenesin 1.2 gram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin anhydrous (as amoxicillin) 775 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely nevirapine 50 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely metoprolol tartrate (as metoprolol succinate) 25 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely metoprolol tartrate (as metoprolol succinate) 50 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely metoprolol tartrate (as metoprolol succinate) 100 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely metoprolol tartrate (as metoprolol succinate) 200 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely fostemsavir 600 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely ferrous sulfate 325 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely upadacitinib 15 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely cefaclor 375 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely ranolazine 375 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely paroxetine (as paroxetine hydrochloride) 25 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely aminophylline hydrate 225 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely aminophylline hydrate 350 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely biperiden hydrochloride 4 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely tramadol hydrochloride 50 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely venlafaxine (as venlafaxine hydrochloride) 37.5 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely venlafaxine (as venlafaxine hydrochloride) 225 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely budesonide 9 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely quetiapine (as quetiapine fumarate) 50 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely quetiapine (as quetiapine fumarate) 150 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely clarithromycin (as clarithromycin citrate) 500 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier

Start Previous Page 3 of 5 Next End

This concept is not in any reference sets

Back to Start